Deborah Neklason
Research Professor
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (6)
Specific MC1R genotypes confer an increased risk of developing LM/LMM. The heatmaps display the percentage frequencies of MC1R genotypes within two cohorts: ( A ) Mohs LM/LMM cohort and ( B ) the Utah reference group. The heatmaps are color-coded to reflect genotype percentages, with red indicating higher frequencies and green indicating lower frequencies. This comparison highlights the differential distribution of MC1R genotypes between patients with LM/LMM and the Utah reference group. * denotes samples for which we calculated an OR compared with WT or heterozygous/homozygous genotypes.
Year:
2025
MC1R variant allele frequencies vary between the Utah reference group and LM/LMM cohorts. A, Bar graph of MC1R allele frequencies in different populations derived from the dSNP database, N = 24,662–123,831. B, Bar graph comparing the European dbSNP data ( N = 18,644–111,821) with the Utah reference group ( N = 402). C, Bar graph comparing the European dbSNP data ( N = 18,644–111,821) with the LM/LMM cohort ( N = 175). D, Bar graph comparing the MC1R allele frequencies between the LM/LMM cohort ( N = 175) and the Utah reference group ( N = 402). Significance in B–D was assessed using Fisher’s exact test, with a P value P value significance thresholds:
Year:
2025
Lentigo maligna (LM) and lentigo maligna melanoma (LMM) arise from chronically sun-damaged skin. LM/LMM incidence continues to increase, particularly in Utah, where melanoma rates are twice the national average. The melanocortin-1 receptor ( MC1R ) has been studied in melanocyte pigmentation and DNA repair but has yet to be thoroughly investigated in LM/LMM. We investigated allele and genotype frequencies of germline MC1R variants among 175 Utah patients diagnosed with LM/LMM and 402 Utah reference individuals. The comparative analysis demonstrated an increased frequency of the D294H allele (0.046; P = 0.0042) and a decreased frequency of the V60L allele (0.074; P = 0.034) in patients with LM/LMM. The LM/LMM group demonstrated a higher OR compared with the Utah reference group associated with R151C homozygosity compared with heterozygous R151C [OR = 5.6; 95% confidence interval (CI), 0.98–32; P = 0.052] and R151C homozygosity compared with wild type (OR = 5.7; 95% CI, 1.1–30; P = 0.042). D294H heterozygosity was strongly associated with LM/LMM (OR = 3.8; 95% CI, 1.3–11; P = 0.014). Conversely, V60L heterozygosity was less strongly associated with LM/LMM (OR = 0.52; 95% CI, 0.26–1.1; P = 0.072). Stratified analyses showed no significant differences in age or gender across the key MC1R variants studied. These data highlight significant differences in MC1R allele frequencies in patients with LM/LMM, demonstrating that D294H is associated with increased LM/LMM risk, whereas the V60L variant is inversely associated with risk. This study provides the first comprehensive analysis of specific high-risk MC1R variants in patients with LM/LMM in Utah. Significance: Our study is the first comprehensive analysis of MC1R germline variants in patients with LM/LMM in Utah, a region with an exceptionally high melanoma incidence. We draw new risk associations in LM/LMM, identifying an increased risk with the D294H and R151C variants. We also describe a novel inverse association for V60L, warranting further investigation. This study contributes to improved targeted risk stratification and an increased understanding of an understudied melanoma subtype.
Year:
2025
Context Autoimmune hypothyroidism, commonly known as Hashimoto thyroiditis (HT), is an autoimmune thyroid disorder affecting approximately 5% of the US population. Previous relative risk studies have suggested that first-degree relatives of individuals with HT are at ∼4.5 to 32 times higher risk for developing HT than the general population. Twin studies estimate high heritability for the development of HT (∼65%). Objective In this study, we aimed to better estimate the HT relative risk in first-, second-, and third-degree relatives in the Utah Population Database. Methods From the Utah Population Database, a total of 92 405 HT probands and 184 810 matched controls were identified, with 2 960 650 relatives of HT probands and 5 730 159 relatives of controls, making this the largest relative risk study of HT. Results Females with HT in this cohort were 2.71-fold more common than males. The odds ratio (OR) of HT in the first-degree relatives of affected individuals is 1.77 (95% CI, 1.74-1.80). The OR of HT in second-degree relatives is 1.23 (95% CI, 1.22-1.27) and 1.11 (95% CI, 1.10-1.12) in third-degree relatives of HT probands. We also identified an increased OR of spouses to develop HT of 1.50 for husbands of affected wives (95% CI, 1.39-1.61) and 1.58 for wives of affected husbands (95% CI, 1.47-1.70), suggesting a significant environmental component contributing to HT development. Conclusion This is the first study to estimate an increased risk of HT for second- and third-degree relatives, who are less likely to share common environments than first-degree relatives.
Year:
2025
Pathogenic germline variants in the APC gene result in familial adenomatous polyposis (FAP) which can escalate into colon cancer. Standard clinical testing failed to identify pathogenic variants in a 4‐generation FAP family. We identified and assessed co‐segregation of a 5′ untranslated region (UTR) variant, NM_001127511.3 ( APC ) c.‐40G>A (GRCh37 chr5:112043375) that creates a potential out‐of‐frame AUG start codon. The segregation odds of pathogenicity for the APC c.‐40G>A variant are 159:1. Translation initiation confidence values for all possible AUGs in the 5′ UTR created by a single nucleotide substitution were calculated using PreTIS online tool. The ‐40G>A variant scored the highest possible confidence value. To test ‐40G>A as an initiating methionine, we created reporter constructs consisting of the entire 5′ UTR and first 81 bases of APC driving luciferase. When the ‐40G>A variant was present, luciferase activity was decreased to 14%–25% of the wild‐type construct. When the premature start codon created by the ‐40G>A variant was in‐frame with luciferase, we observed luciferase activity from this de novo false start site. Combined, our evidence supports classification of APC c.‐40G>A to likely pathogenic, presumably through squelching of the canonical AUG start codon. More importantly, it underlines the feasibility and importance of clinical laboratories to screen noncoding regions.
Year:
2025
Recent advances in genome sequencing have improved variant calling in complex regions of the human genome. However, it is difficult to quantify variant calling performance since existing standards often focus on specificity, neglecting completeness in difficult to analyze regions. To create a more comprehensive truth set, we used Mendelian inheritance in a large pedigree (CEPH-1463) to filter variants across Illumina, PacBio high-fidelity (HiFi), and Oxford Nanopore Technologies platforms. This generated a variant map with over 4.7 million single-nucleotide variants, 767,795 indels, 537,486 tandem repeats, and 24,315 structural variants, covering 2.77 Gb of the GRCh38 genome. This work adds ~200 Mb of high-confidence regions, including 8% more small variants, and introduces the first tandem repeat and structural variant truth sets for NA12878. As an example of the value of this improved benchmark, we retrained DeepVariant using this data to reduce genotyping errors by ~34%.
Year:
2024
Collaborators (14)
Amanda Jiang
Huntsman Cancer Institute
Andrea Guarracino
Assistant Professor
Translational Genomics Research Institute
Erik Garrison
Associate Professor
University of Tennessee Health Science Center
Dekker Deacon
Assistant Professor
University of Utah
Justin Zook
National Institute of Standards and Technology
W. Scott Watkins
University of Utah
Evan Eichler
Howard Hughes Medical Institute
Peter Lansdorp
Professor
The University of British Columbia
Bing-Jian Feng
Research Associate Professor
University of Utah
Douglas Grossman
Professor
University of Utah Health Sciences Center
Robert Judson‐Torres
-
Nathanael Olson
National Institute of Standards and Technology
Harriet Dashnow
Assistant Professor
University of Colorado Anschutz Medical Campus
Jessica Donigan
Assistant Professor
University of Utah
Make your next move.
Prepare your application
Review drafts before you send them.